| Effect of fibrates on postprandial remnant-like particles in patients with combined hyperlipidemia. | |
| | |
MedLine Citation:
|
PMID: 15019549 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We have investigated the effect of standard doses of two fibrates, gemfibrozil and fenofibrate, on fasting and postprandial remnant-like particles (RLP) in subjects with combined hyperlipidemia. Forty-eight subjects participated; of these, 14 underwent a Vitamin A-fat loading test before and after 6 months of treatment with gemfibrozil (n = 8) and fenofibrate (n = 6). Blood was drawn every 2h for 12h after the test meal. The postprandial response was calculated as the area under the curve (AUC). There was no difference in fasting levels and pre-treatment AUC for triglycerides (TG), RLP cholesterol (RLP-C), RLP triglycerides (RLP-TG) and retinyl palmitate (RetP) between the two treatment groups. There was also no difference in the treatment effect on all parameters between the two treatment groups. Combining the two treatment groups, treatment resulted in a significant reduction in fasting levels and AUC of all four parameters. Assigning the difference observed between pre-treatment AUC of the combined study group and AUC of a normolipidemic (NL) control group as 100%, fibrate treatment resulted in decreases in AUC for TG, RLP-C, RLP-TG and RetP of 68, 69, 69 and 94%, respectively. These results indicate that fibrates are effective agents in reducing the postprandial increase in remnant lipoprotein particles. |
| | |
Authors:
|
T C Ooi; M Cousins; D S Ooi; K Nakajima; A L Edwards |
Related Documents
:
|
12466009 - Stavudine once daily. 12074829 - Ldl and hdl subclass distribution in patients with end-stage renal diseases. 20371759 - Adherence to a fixed-dose combination of rosiglitazone/glimepiride in subjects switchin... 16464519 - Short-term atorvastatin treatment enhances specific antibody production following tetan... 20079899 - Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, rand... 21341969 - Medically unexplained dyspnea: partly moderated by dysfunctional (thoracic dominant) br... 23049569 - Add-on lamotrigine treatment for subsyndromal depression after manic or mixed states in... 22927609 - Clinical and demographic factors associated with employment status in us military veter... 15465879 - Anticoagulant treatment of patients with chronic atrial fibrillation in primary health ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Atherosclerosis Volume: 172 ISSN: 0021-9150 ISO Abbreviation: Atherosclerosis Publication Date: 2004 Feb |
Date Detail:
|
Created Date: 2004-03-15 Completed Date: 2004-06-04 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0242543 Medline TA: Atherosclerosis Country: Ireland |
Other Details:
|
Languages: eng Pagination: 375-82 Citation Subset: IM |
Affiliation:
|
Metabolism and Hormone Laboratory, Division of Endocrinology and Metabolism, Department of Medicine, Ottawa Hospital, University of Ottawa, Civic Campus, 1053 Carling Avenue, Ottawa, Ont., Canada K1Y 4E9. tcooi@ottawahospital.on.ca |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antilipemic Agents
/
pharmacology* Cholesterol / blood Dietary Fats / metabolism Fasting Female Gemfibrozil / pharmacology* Humans Hyperlipidemia, Familial Combined / blood* Lipoproteins / blood* Male Middle Aged Postprandial Period Procetofen / pharmacology* Triglycerides / blood Vitamin A / analogs & derivatives*, blood, metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Antilipemic Agents; 0/Dietary Fats; 0/Lipoproteins; 0/Triglycerides; 11103-57-4/Vitamin A; 25812-30-0/Gemfibrozil; 49562-28-9/Procetofen; 57-88-5/Cholesterol; 79-81-2/retinol palmitate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Lack of evidence for reduced plasma apo B48 catabolism in patients with heterozygous familial hyperc...
Next Document: Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid Metabolic ...